{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T03:43:11Z","timestamp":1790998991412,"version":"4.1.0"},"reference-count":28,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","redjournal.org","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Radiation Oncology*Biology*Physics"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.ijrobp.2024.09.022","type":"journal-article","created":{"date-parts":[[2024,9,17]],"date-time":"2024-09-17T19:32:36Z","timestamp":1726601556000},"page":"432-441","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Comparison of Metastasectomy and Stereotactic Body Radiation Therapy for Pulmonary Oligometastasis From Hepatocellular Carcinoma: A Propensity Score-Weighted Analysis"],"prefix":"10.1016","volume":"121","author":[{"given":"Young Seob","family":"Shin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jae Kwang","family":"Yun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinhong","family":"Jung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin-hong","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Si Yeol","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eun Kyung","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sehoon","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyeong Ryul","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong-Hee","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong Kwan","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geun Dong","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5138-3051","authenticated-orcid":false,"given":"Sang Min","family":"Yoon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl 2","key":"10.1016\/j.ijrobp.2024.09.022_bib0001","doi-asserted-by":"crossref","first-page":"S361","DOI":"10.21037\/jgo.2020.02.08","article-title":"Addressing the worldwide hepatocellular carcinoma: epidemiology, prevention and management","volume":"12","author":"Samant","year":"2021","journal-title":"J Gastrointest Oncol"},{"key":"10.1016\/j.ijrobp.2024.09.022_bib0002","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1159\/000510798","article-title":"Impact of extrahepatic metastases on overall survival in patients with advanced liver dominant hepatocellular carcinoma: a subanalysis of the SORAMIC trial","volume":"9","author":"Sch\u00fctte","year":"2020","journal-title":"Liver Cancer"},{"key":"10.1016\/j.ijrobp.2024.09.022_bib0003","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1056\/NEJMoa1915745","article-title":"Atezolizumab plus bevacizumab in unresectable hepatocellular carcinoma","volume":"382","author":"Finn","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijrobp.2024.09.022_bib0004","doi-asserted-by":"crossref","first-page":"2178","DOI":"10.1007\/s00268-016-3580-4","article-title":"Prognostic analysis of surgical resection for pulmonary metastasis from hepatocellular carcinoma","volume":"40","author":"Takahashi","year":"2016","journal-title":"World J Surg"},{"key":"10.1016\/j.ijrobp.2024.09.022_bib0005","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1200\/JCO.19.00201","article-title":"Local consolidative therapy vs maintenance therapy or observation for patients with oligometastatic non-small-cell lung cancer: long-term results of a multi-institutional, phase II, randomized study","volume":"37","author":"Gomez","year":"2019","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2024.09.022_bib0006","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1001\/jamaoncol.2020.0147","article-title":"Outcomes of observation vs stereotactic ablative radiation for oligometastatic prostate cancer: the ORIOLE phase 2 randomized clinical trial","volume":"6","author":"Phillips","year":"2020","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.ijrobp.2024.09.022_bib0007","doi-asserted-by":"crossref","first-page":"2813","DOI":"10.1007\/s10620-014-3229-9","article-title":"Epidemiology of metastatic hepatocellular carcinoma, a nationwide perspective","volume":"59","author":"Abbas","year":"2014","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.ijrobp.2024.09.022_bib0008","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1016\/j.jtcvs.2019.11.132","article-title":"Sublobar resection compared with stereotactic body radiation therapy and ablation for early stage non-small cell lung cancer: a national cancer database study","volume":"160","author":"Wu","year":"2020","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.ijrobp.2024.09.022_bib0009","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/S1470-2045(15)70168-3","article-title":"Stereotactic ablative radiotherapy versus lobectomy for operable stage I non-small-cell lung cancer: a pooled analysis of two randomised trials","volume":"16","author":"Chang","year":"2015","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ijrobp.2024.09.022_bib0010","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.clon.2020.01.005","article-title":"Stereotactic body radiotherapy versus metastasectomy in patients with pulmonary metastases from soft tissue sarcoma","volume":"32","author":"Tetta","year":"2020","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"10.1016\/j.ijrobp.2024.09.022_bib0011","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1093\/jjco\/hyac028","article-title":"Stereotactic ablative radiotherapy for pulmonary oligometastases from primary hepatocellular carcinoma: a multicenter and retrospective analysis (KROG 17-08)","volume":"52","author":"Jo","year":"2022","journal-title":"Jpn J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2024.09.022_bib0012","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","article-title":"New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)","volume":"45","author":"Eisenhauer","year":"2009","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ijrobp.2024.09.022_bib0013","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1038\/s41571-022-00655-9","article-title":"The oligometastatic spectrum in the era of improved detection and modern systemic therapy","volume":"19","author":"Katipally","year":"2022","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.ijrobp.2024.09.022_bib0014","doi-asserted-by":"crossref","first-page":"1","DOI":"10.17998\/jlc.2022.11.07","article-title":"2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma","volume":"23","year":"2023","journal-title":"J Liver Cancer"},{"key":"10.1016\/j.ijrobp.2024.09.022_bib0015","doi-asserted-by":"crossref","first-page":"252","DOI":"10.3350\/cmh.2023.0099","article-title":"Overview of Asian clinical practice guidelines for the management of hepatocellular carcinoma: an Asian perspective comparison","volume":"29","author":"Cho","year":"2023","journal-title":"Clin Mol Hepatol"},{"key":"10.1016\/j.ijrobp.2024.09.022_bib0016","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/j.jhep.2021.11.018","article-title":"BCLC strategy for prognosis prediction and treatment recommendation: the 2022 update","volume":"76","author":"Reig","year":"2022","journal-title":"J Hepatol"},{"key":"10.1016\/j.ijrobp.2024.09.022_bib0017","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1016\/j.athoracsur.2019.06.086","article-title":"Clinical factors predictive of a better prognosis of pulmonary metastasectomy for hepatocellular carcinoma","volume":"108","author":"Wang","year":"2019","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.ijrobp.2024.09.022_bib0018","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1097\/JTO.0b013e3181e2fc9b","article-title":"Prognostic factors for pulmonary metastasectomy in the treatment of hepatocellular carcinoma","volume":"5","author":"Cho","year":"2010","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.ijrobp.2024.09.022_bib0019","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1159\/000477134","article-title":"Clinical factors predicting better survival outcome for pulmonary metastasectomy of hepatocellular carcinoma","volume":"6","author":"Kuo","year":"2017","journal-title":"Liver Cancer"},{"key":"10.1016\/j.ijrobp.2024.09.022_bib0020","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.lungcan.2010.02.014","article-title":"Role of surgical resection for pulmonary metastasis of hepatocellular carcinoma","volume":"70","author":"Han","year":"2010","journal-title":"Lung Cancer"},{"key":"10.1016\/j.ijrobp.2024.09.022_bib0021","doi-asserted-by":"crossref","first-page":"FSO471","DOI":"10.2144\/fsoa-2019-0120","article-title":"Surgery versus stereotactic radiotherapy for treatment of pulmonary metastases. A systematic review of literature","volume":"6","author":"Londero","year":"2020","journal-title":"Future Sci OA"},{"key":"10.1016\/j.ijrobp.2024.09.022_bib0022","doi-asserted-by":"crossref","first-page":"48586","DOI":"10.18632\/oncotarget.9374","article-title":"Simultaneous multitarget radiotherapy using helical tomotherapy and its combination with sorafenib for pulmonary metastases from hepatocellular carcinoma","volume":"7","author":"Sun","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.ijrobp.2024.09.022_bib0023","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.ijrobp.2017.12.288","article-title":"Local control after stereotactic body radiation therapy for liver tumors","volume":"110","author":"Ohri","year":"2021","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2024.09.022_bib0024","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.3390\/cancers15041195","article-title":"Stereotactic body radiotherapy versus surgery for lung metastases from colorectal cancer: single-institution results","volume":"15","author":"Garcia-Exposito","year":"2023","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.ijrobp.2024.09.022_bib0025","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1056\/NEJMoa0708857","article-title":"Sorafenib in advanced hepatocellular carcinoma","volume":"359","author":"Llovet","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijrobp.2024.09.022_bib0026","doi-asserted-by":"crossref","DOI":"10.1056\/EVIDoa2100070","article-title":"Tremelimumab plus durvalumab in unresectable hepatocellular carcinoma","volume":"1","author":"Abou-Alfa","year":"2022","journal-title":"NEJM Evid"},{"key":"10.1016\/j.ijrobp.2024.09.022_bib0027","doi-asserted-by":"crossref","first-page":"329","DOI":"10.6004\/jnccn.2021.0012","article-title":"Colon cancer, version 2.2021, NCCN clinical practice guidelines in oncology","volume":"19","author":"Benson","year":"2021","journal-title":"J Natl Compr Canc Netw"},{"key":"10.1016\/j.ijrobp.2024.09.022_bib0028","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.prro.2023.04.004","article-title":"Treatment of oligometastatic non-small cell lung cancer: an ASTRO\/ESTRO clinical practice guideline","volume":"13","author":"Iyengar","year":"2023","journal-title":"Pract Radiat Oncol"}],"container-title":["International Journal of Radiation Oncology*Biology*Physics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301624033935?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301624033935?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,15]],"date-time":"2025-01-15T23:18:30Z","timestamp":1736983110000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0360301624033935"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":28,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["S0360301624033935"],"URL":"https:\/\/doi.org\/10.1016\/j.ijrobp.2024.09.022","relation":{},"ISSN":["0360-3016"],"issn-type":[{"value":"0360-3016","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparison of Metastasectomy and Stereotactic Body Radiation Therapy for Pulmonary Oligometastasis From Hepatocellular Carcinoma: A Propensity Score-Weighted Analysis","name":"articletitle","label":"Article Title"},{"value":"International Journal of Radiation Oncology*Biology*Physics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijrobp.2024.09.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}